Estrogen Deprivation and Inhibition of Breast Cancer Growth in Vivo through Activation of the Orphan Nuclear Receptor Liver X Receptor
Authors:
Open Access
- 1 August 2007
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 21 (8) , 1781-1790
Abstract
Estrogen plays an important role in normal physiology. It is also a risk factor for breast cancer, and antiestrogen therapies have been shown to be effective in the treatment and prevention of breast cancers. The liver is important for estrogen metabolism, and a compromised liver function has been linked to hyperestrogenism in patients. In this report, we showed that the liver X receptor (LXR) controls estrogen homeostasis by regulating the basal and inducible hepatic expression of estrogen sulfotransferase (Est, or Sult1e1), an enzyme critical for metabolic estrogen deactivation. Genetic or pharmacological activation of LXR resulted in Est induction, which in turn inhibited estrogen-dependent uterine epithelial cell proliferation and gene expression, as well as breast cancer growth in a nude mouse model of tumorigenicity. We further established that Est is a transcriptional target of LXR, and deletion of the Est gene in mice abolished the LXR effect on estrogen deprivation. Interestingly, Est regulation by LXR appeared to be liver specific, further underscoring the role of liver in estrogen metabolism. Activation of LXR failed to induce other major estrogen-metabolizing enzymes, suggesting that the LXR effect on estrogen metabolism is Est specific. In summary, our results have revealed a novel mechanism controlling estrogen homeostasis in vivo and may have implications for drug development in the treatment of breast cancer and other estrogen-related cancerous endocrine disorders.Keywords
This publication has 46 references indexed in Scilit:
- Estrogen receptors and human diseaseJournal of Clinical Investigation, 2006
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- A Life-Long Search for the Molecular Pathways of Steroid Hormone ActionMolecular Endocrinology, 2005
- Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase—deficient miceNature Medicine, 2005
- From chemical warfare to breast cancer managementNature Medicine, 2004
- A comparative review of the risks and benefits of hormone replacement therapy regimensAmerican Journal of Obstetrics and Gynecology, 2004
- Biological Role of Estrogen and Estrogen ReceptorsCritical Reviews in Biochemistry and Molecular Biology, 2002
- Biochemistry and Reproductive Endocrinology of Estrogen SulfotransferaseAnnals of the New York Academy of Sciences, 2001
- Targeted Disruption of the Mouse Estrogen Sulfotransferase Gene Reveals a Role of Estrogen Metabolism in Intracrine and Paracrine Estrogen RegulationEndocrinology, 2001
- Mouse Steroid SulfotransferasesBiochemical Pharmacology, 1998